Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

FIGS, Inc. Class A Common Stock (NY:FIGS)

4.510 -0.010 (-0.22%)
Streaming Delayed Price Updated: 1:21 PM EDT, May 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about FIGS, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
10 Consumer Discretionary Stocks With Whale Alerts In Today's Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 17, 2023
Via Benzinga
The Latest Analyst Ratings for FIGS
Via Benzinga
Figs (FIGS) Q1 2023 Earnings Call Transcript
FIGS earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Analyst Ratings for FIGS
Via Benzinga
What 8 Analyst Ratings Have To Say About FIGS
Via Benzinga
Figs Stock Is Down Nearly 90% From Its High. Time to Buy?
The medical apparel maker faces tough near-term headwinds. 
Via The Motley Fool
FIGS Announces Participation in the TD Cowen Future of the Consumer Conference
From FIGS, Inc.
Via Business Wire
This Analyst With 83% Accuracy Rate Sees Around 11% Upside In Texas Roadhouse - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
U.S stocks closed higher on Friday, with the Dow Jones jumping more than 500 points during the session. 
Via Benzinga
FIGS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of FIGS, Inc. - FIGS
From Kahn Swick & Foti, LLC
Via Business Wire
FIGS Releases First Quarter 2023 Financial Results
From FIGS, Inc.
Via Business Wire
$5M Bet On FIGS? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed mixed on Wednesday, there were a few notable insider trades. 
Via Benzinga
Analyst Ratings for FIGS
Via Benzinga
Figs (FIGS) Q4 2022 Earnings Call Transcript
FIGS earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023
Via Benzinga
Bragar Eagel & Squire is Investigating Certain Officers and Directors of FIGS, and Opendoor on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
FIGS Announces Date of First Quarter 2023 Earnings Release, Conference Call and Webcast
From FIGS, Inc.
Via Business Wire
FIGS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of FIGS, Inc. - FIGS
From Kahn Swick & Foti, LLC
Via Business Wire
FIGS Releases Its 2022 Impact Report
From FIGS, Inc.
Via Business Wire
3 No-Brainer Stocks to Buy Right Now for Less than $25
Down between 86% to 92% from all-time highs, these stocks now trade at prices that make them worthy of a closer look. 
Via The Motley Fool
Meta Platforms To Rally Over 26%? Here Are 10 Other Analyst Forecasts For Tuesday
Morgan Stanley boosted the price target for HubSpot, Inc. (NYSE: HUBS) from $447 to $466. Morgan Stanley analyst Keith Weiss maintained an Overweight rating. HubSpot shares fell 1.9% to close at... 
Via Benzinga
The Good News From Salesforce
And we talk about people pulling back on spending on all those things that probably seemed essential in the earlier days of the pandemic. 
Via The Motley Fool
FIGS, Inc. (NYSE:FIGS) Long Term Investor Alert: Investigation of Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 03/03/2023 -- An investigation on behalf of current long-term investors in shares of FIGS, Inc. (NYSE:FIGS) concerning potential breaches of fiduciary duties by certain... 
Via SBWire
FIGS Announces Participation in the KeyBanc Emerging Technology Summit
From FIGS, Inc.
Via Business Wire
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
FIGS Announces Participation in the Raymond James Institutional Investors Conference
From FIGS, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Shares of Figs Inc. Are Trading Lower On Earnings Beat: What's Going On?
Shares of Figs Inc (NYSE: FIGS) are trading lower into Tuesday’s after-market session following an earnings beat. Here’s what investors need to know. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.